| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 22, 2019 | May 24, 2019 | Cloonan Michael Chief Business Officer | Sell | Sage Therapeutics, Inc. | SAGE | $175 | $4M | -98.19% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.